Analysis Examines the Implications of Price Transparency for Providers and Patients as New Rules Go into Effect January 13, 2021 News Release A new KFF analysis examines how new federal rules on price transparency for health services may affect patient decision-making and market pricing. As of January 1, 2021, the United States Department of Health and Human Services requires that hospitals publish payer-negotiated rates for common services on their websites. A second…
Price Transparency and Price Variation in U.S. Health Services January 13, 2021 Issue Brief A new Peterson-KFF analysis examines the potential impact of new federal price transparency rules on patient decision-making and market pricing for health services. The brief also includes new analysis of geographic variation in health prices.
Medicare Accelerated and Advance Payments for COVID-19 Revenue Loss: More Time to Repay October 8, 2020 Issue Brief This brief provides an overview and status update of the Medicare accelerated and advance payment program, which provided $100 billion in loans to Medicare providers in the spring of 2020 to compensate for revenue shortfalls due to the coronavirus pandemic. The brief describes who got the funds, and how these loans are distinct from other funds that providers received, which do not have to be repaid.
The Cost of Inpatient and Outpatient Care Drives High Health Spending in the U.S. Relative to Other Countries, New Analysis Finds October 1, 2020 News Release A new KFF issue brief compares the main drivers of health spending in the United States and other large, wealthy countries, and finds that the cost of inpatient and outpatient care – much more so than prescription drugs or administrative costs – drives high per capita health spending in the U.S.…
Drugs Aren’t the Reason the U.S. Spends So Much on Health Care September 30, 2020 Perspective Drew Altman’s column in Axios: the U.S. now spends twice per capita what other wealthy countries do on health care. But while drug costs get all the time in public debate, it’s hospital and outpatient spending that mostly explains the difference. And that will be impossible to take on without real pain and political risk, he says.
Analysis Compares President Trump and Democratic Nominee Biden on COVID-19 September 11, 2020 News Release Few issues are likely to matter as much to voters in November’s presidential election as President Trump’s response to the COVID-19 pandemic and resulting economic crisis, which have left almost 200,000 Americans dead and prompted job layoffs and furloughs affecting tens of millions of Americans. A new election brief compares…
Comparing Trump and Biden on COVID-19 September 11, 2020 Issue Brief This issue brief compares President Trump and Democratic nominee Joe Biden on their records, actions and proposals related to the COVID-19 pandemic. It includes a general overview of their respective approaches, followed by a detailed side-by-side.
Medicare’s Finances Have Gotten Much Worse in Recent Years, Foreshadowing Tough Choices for November’s Winners September 3, 2020 Blog This policy watch post discusses the latest Medicare Hospital Insurance trust fund solvency projections from the Congressional Budget Office (CBO), which show the extent to which the COVID-19 pandemic has hurt Medicare’s financial outlook, and foreshadow the tough choices facing the next President and Congress.